Fundamentals - AlphaKey Financial

Stock Fundamentals

Company Information

▼

Company Name

Immutep Ltd ADR

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ISIN: US45257L1089

CIK: 0001692528

CUSIP: 74154B302

Currency: USD

Full Time Employees: 0

Phone: 61 2 8315 7003

Website: https://www.immutep.com

Fiscal Year End: June

IPO Date: Apr 17, 2012

Description:

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.

Address:

Australia Square, Sydney, NSW, Australia, 2000

Directors & Officers

▼

Name	Title	Year Born
Mr. Marc Voigt	CEO, MD, CFO, Chief Business Officer & Executive Director	1973
Ms. Deanne Miller LLB	COO, General Counsel & Joint Company Secretary	1977
Dr. Frederic Triebel M.D., Ph.D.	Chief Scientific Officer & Executive Director	1955
Mr. Christian Mueller BBA, MSc.	Chief Development Officer	NA
Dr. Stephan Winckels M.D., Ph.D.	Chief Medical Officer	NA
Ms. Indira Naidu	Joint Company Secretary	NA

Institutional Holders

▼

Holder Name	Shares	Date Reported	% Out	Value	% Change
BlackRock Inc	580.44K	Sep 30, 2025	0.39%	$0.00	-3.25%
Meridian Wealth Management, LLC	454.40K	Dec 31, 2025	0.31%	$0.05	7.96%
Sender Co & Partners, Inc.	215.86K	Sep 30, 2025	0.15%	$0.04	75.85%
Morgan Stanley - Brokerage Accounts	165.97K	Sep 30, 2025	0.11%	$0.00	38.92%
Susquehanna International Group, LLP	95.25K	Sep 30, 2025	0.06%	$0.00	63.36%
Two Sigma Investments LLC	94.60K	Dec 31, 2025	0.06%	$0.00	0.00%
Verition Fund Managegment, LLC	60.00K	Dec 31, 2025	0.04%	$0.00	-20.00%
Jane Street Group LLC	55.46K	Sep 30, 2025	0.04%	$0.00	0.00%
Steward Partners Investment Advisory, LLC	55.00K	Sep 30, 2025	0.04%	$0.00	-9.84%
Millennium Management LLC	49.30K	Sep 30, 2025	0.03%	$0.00	0.00%
Citadel Advisors Llc	44.07K	Sep 30, 2025	0.03%	$0.00	0.00%
LPL Financial Corp	33.98K	Sep 30, 2025	0.02%	$0.00	0.00%
XTX Topco Ltd	33.83K	Sep 30, 2025	0.02%	$0.00	112.38%
Dimensional Fund Advisors, Inc.	33.12K	Dec 31, 2025	0.02%	$0.00	-5.83%
Hilton Capital Management, LLC	30.68K	Dec 31, 2025	0.02%	$0.01	0.00%
Virtu Financial LLC	28.12K	Sep 30, 2025	0.02%	$0.00	0.00%
Fortitude Advisory Group L.L.C.	26.50K	Sep 30, 2025	0.02%	$0.02	119.01%
UBS Group AG	25.09K	Sep 30, 2025	0.02%	$0.00	-61.30%
Rhumbline Advisers	21.83K	Sep 30, 2025	0.01%	$0.00	-18.28%
Geode Capital Management, LLC	18.72K	Sep 30, 2025	0.01%	$0.00	0.00%

Shares Statistics

▼

Shares Outstanding: 147.19M

Shares Float: 1.23B

% Insiders: 1.20%

% Institutions: 210.70%

Short % Float: 3.27%

🏆 Top 10 Institutional Holders

▼

Rank	Holder Name	Shares Held	% of Shares	Change	Date Reported
1	BlackRock Inc	580.44K	0.39%	▼ 3.25%	Sep 30, 2025
2	Meridian Wealth Management, LLC	454.40K	0.31%	▲ 7.96%	Dec 31, 2025
3	Sender Co & Partners, Inc.	215.86K	0.15%	▲ 75.85%	Sep 30, 2025
4	Morgan Stanley - Brokerage Accounts	165.97K	0.11%	▲ 38.92%	Sep 30, 2025
5	Susquehanna International Group, LLP	95.25K	0.06%	▲ 63.36%	Sep 30, 2025
6	Two Sigma Investments LLC	94.60K	0.06%	▲ 0.00%	Dec 31, 2025
7	Verition Fund Managegment, LLC	60.00K	0.04%	▼ 20.00%	Dec 31, 2025
8	Jane Street Group LLC	55.46K	0.04%	▲ 0.00%	Sep 30, 2025
9	Steward Partners Investment Advisory, LLC	55.00K	0.04%	▼ 9.84%	Sep 30, 2025
10	Millennium Management LLC	49.30K	0.03%	▲ 0.00%	Sep 30, 2025

Valuation Metrics

▼

Enterprise Value: $311.47M

Trailing P/E: 0.00

Forward P/E: 7.65

Financial Highlights

▼

Market Cap: $412.14M

EBITDA: $-81.38M

Book Value: $0.05

Earnings/Share: $-0.42

Profit Margin: 0.00%

Operating Margin: -763.71%

ROA (TTM): -32.10%

ROE (TTM): -61.85%

Revenue (TTM): $7.92M

Revenue/Share (TTM): $0.05

Earnings Growth (YOY): 0.00%

Revenue Growth (YOY): 91.50%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Date	EPS Actual	EPS Estimate	Difference	Surprise %
Dec 31, 2025	N/A	-0.15	N/A	N/A
Sep 30, 2025	0.00	0.00	N/A	N/A
Jun 30, 2025	-0.03	-0.15	N/A	8,019.80%
Mar 31, 2025	0.00	0.00	N/A	N/A
Dec 31, 2024	-0.02	-0.14	N/A	8,571.43%
Sep 30, 2024	0.00	0.00	N/A	N/A
Jun 30, 2024	0.00	-0.13	N/A	10,000.00%
Mar 31, 2024	0.00	0.00	N/A	N/A
Dec 31, 2023	-0.18	-0.13	N/A	-4,073.49%
Sep 30, 2023	0.00	0.00	N/A	N/A
Jun 30, 2023	-0.15	-0.16	N/A	737.50%
Mar 31, 2023	0.00	0.00	N/A	N/A
Dec 31, 2022	-0.15	-0.16	N/A	325.81%
Sep 30, 2022	0.00	0.00	N/A	N/A
Jun 30, 2022	0.00	-0.16	N/A	10,000.00%
Mar 31, 2022	0.00	0.00	N/A	N/A
Dec 31, 2021	0.00	-0.23	N/A	10,000.00%
Sep 30, 2021	0.00	0.00	N/A	N/A
Jun 30, 2021	0.00	-0.38	N/A	10,000.00%
Mar 31, 2021	-0.01	0.00	N/A	N/A
Dec 31, 2020	-0.38	-0.36	N/A	-555.56%
Sep 30, 2020	-0.01	0.00	N/A	N/A
Jun 30, 2020	-0.01	0.00	N/A	N/A
Mar 31, 2020	-0.01	0.00	N/A	N/A
Dec 31, 2019	-0.01	0.00	N/A	N/A
Sep 30, 2019	-0.01	0.00	N/A	N/A
Jun 30, 2019	-0.01	0.00	N/A	N/A
Mar 31, 2019	-0.01	0.00	N/A	N/A
Dec 31, 2018	-0.01	0.00	N/A	N/A
Sep 30, 2018	-0.01	0.00	N/A	N/A
Jun 30, 2018	-0.01	0.00	N/A	N/A
Mar 31, 2018	-0.01	0.00	N/A	N/A
Dec 31, 2017	-0.01	0.00	N/A	N/A
Sep 30, 2017	-0.01	0.00	N/A	N/A
Jun 30, 2017	-0.01	0.00	N/A	N/A
Mar 31, 2017	-0.08	0.00	N/A	N/A
Dec 31, 2016	-0.01	-0.36	N/A	9,766.67%
Sep 30, 2016	-0.01	0.00	N/A	N/A
Jun 30, 2016	-0.01	0.00	N/A	N/A
Mar 31, 2016	-0.01	0.00	N/A	N/A
Dec 31, 2015	-0.01	0.00	N/A	N/A
Sep 30, 2015	-0.10	0.00	N/A	N/A
Jun 30, 2015	-0.10	0.00	N/A	N/A
Mar 31, 2015	-0.05	0.00	N/A	N/A
Dec 31, 2014	-0.05	0.00	N/A	N/A
Sep 30, 2014	-0.02	0.00	N/A	N/A
Jun 30, 2014	-0.02	0.00	N/A	N/A
Mar 31, 2014	-0.02	0.00	N/A	N/A
Dec 31, 2013	-0.02	0.00	N/A	N/A
Sep 30, 2013	-0.02	0.00	N/A	N/A
Jun 30, 2013	-0.02	0.00	N/A	N/A
Mar 31, 2013	-0.03	0.00	N/A	N/A
Dec 31, 2012	-0.03	0.00	N/A	N/A
Sep 30, 2012	-0.04	0.00	N/A	N/A
Jun 30, 2012	-0.04	0.00	N/A	N/A
Mar 31, 2012	-0.05	0.00	N/A	N/A
Dec 31, 2011	-0.05	0.00	N/A	N/A
Sep 30, 2011	-0.05	0.00	N/A	N/A
Jun 30, 2011	-0.04	0.00	N/A	N/A
Mar 31, 2011	-0.11	0.00	N/A	N/A
Dec 31, 2010	-0.10	0.00	N/A	N/A
Sep 30, 2010	-0.09	0.00	N/A	N/A

Balance Sheet (Yearly)

▼

Date	Cash	Total Debt	Total Assets	Total Liabilities	Total Equity
2025-06-30	$67.41M	$N/A	$156.98M	$13.35M	$143.64M
2024-06-30	$161.79M	$N/A	$201.58M	$12.06M	$189.52M
2023-06-30	$123.42M	$N/A	$147.45M	$10.98M	$136.47M
2022-06-30	$80.00M	$N/A	$102.17M	$8.09M	$94.08M
2021-06-30	$60.13M	$N/A	$82.03M	$8.76M	$73.27M
2020-06-30	$26.32M	$N/A	$46.60M	$13.30M	$33.30M
2019-06-30	$16.57M	$N/A	$40.54M	$16.15M	$24.39M
2018-06-30	$23.48M	$N/A	$47.00M	$13.48M	$33.52M
2017-06-30	$12.24M	$N/A	$34.96M	$8.43M	$26.53M
2016-06-30	$20.88M	$N/A	$42.55M	$7.24M	$35.32M
2015-06-30	$6.76M	$N/A	$30.98M	$6.29M	$24.69M
2014-06-30	$14.20M	$N/A	$25.38M	$2.79M	$22.59M
2013-06-30	$22.02M	$N/A	$32.81M	$3.57M	$29.25M
2012-06-30	$17.00M	$N/A	$41.61M	$4.45M	$37.16M
2011-06-30	$45.93M	$N/A	$57.64M	$2.54M	$55.10M
2010-06-30	$15.64M	$N/A	$19.01M	$2.22M	$16.79M
2009-06-30	$950.56K	$N/A	$2.49M	$677.10K	$1.81M
2008-06-30	$1.11M	$N/A	$2.82M	$187.82K	$2.63M

Financial Ratios

▼

Date	Current Ratio	Debt/Equity	Debt/Assets	Interest Coverage	Debt/EBITDA
2025-06-30	11.69x	0.01x	0.09x	N/A	-0.02x
2024-06-30	18.25x	0.01x	0.06x	-2,879.79x	-0.03x
2023-06-30	13.81x	0.01x	0.07x	-3,808.07x	-0.03x
2022-06-30	14.16x	0.02x	0.08x	-367.17x	-0.07x
2021-06-30	12.81x	0.04x	0.11x	-3,224.10x	-0.17x
2020-06-30	9.26x	0.27x	0.29x	-1,531.88x	-0.78x
2019-06-30	4.44x	0.31x	0.40x	N/A	-0.46x
2018-06-30	7.43x	0.20x	0.29x	N/A	-0.64x
2017-06-30	6.05x	0.22x	0.24x	N/A	-0.69x
2016-06-30	14.72x	0.14x	0.17x	-7,497.79x	-0.08x
2015-06-30	1.83x	0.06x	0.20x	-0.76x	-0.11x
2014-06-30	8.91x	0.00x	0.11x	N/A	0.00x
2013-06-30	8.93x	0.00x	0.11x	N/A	0.00x
2012-06-30	9.20x	0.00x	0.11x	N/A	0.00x
2011-06-30	22.49x	0.00x	0.04x	-2.21x	0.00x
2010-06-30	7.55x	0.04x	0.12x	-4.41x	-0.06x
2009-06-30	2.03x	0.13x	0.27x	-15.82x	-0.09x
2008-06-30	6.29x	0.00x	0.07x	N/A	0.00x

Stock Fundamentals

Company Information

Directors & Officers

Institutional Holders

Shares Statistics

🏆 Top 10 Institutional Holders

Valuation Metrics

Financial Highlights

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Watchlist

Assistant